Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod
Author:
Affiliation:
1. Department of Dermatology Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan
2. Department of Pathology Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15101
Reference7 articles.
1. Programmed cell death protein-1 inhibitor–induced granuloma annulare and hypertrophic lichen planus masquerading as squamous cell carcinoma
2. Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy
3. Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy
4. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue
5. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features;Human Pathology;2023-10
2. To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma;Archives of Dermatological Research;2022-11-17
3. Molecular and immune targets in cutaneous squamous cell carcinoma;Molecular Carcinogenesis;2022-08-24
4. Cutaneous adverse events caused by immune checkpoint inhibitors;Journal of the American Academy of Dermatology;2021-10
5. Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma;Australasian Journal of Dermatology;2021-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3